Ivan Mishanin is the co-founder and COO of Brainify.AI, an AI/ML biomarker platform for novel treatment development aimed at female depression

Photo by Anthony Tran on Unsplash

Revolutionizing Depression Treatment: Embracing Opportunities in Challenging Times

In this article, we'll take you on a journey through the world of depression treatment development, exploring the challenges and opportunities that lie ahead. From the rising costs of creating new treatments to the cautious approach of the pharmaceutical industry, we'll delve into the complexities of this field and uncover how innovative approaches and collaborations can reshape the future of mental health care.
Most Popular

Recommended Stories